Recombinant Human IL34 protein, Fc-tagged
| Cat.No. : | IL34-215H |
| Product Overview : | Recombinant Human IL34(Asn21-Pro242) fused with the Fc region of mouse IgG2a at N-terminal was expressed in CHO. |
- Specification
- Gene Information
- Related Products
| Description : | Interleukin-34 is a cytokine that promotes the differentiation and viability of monocytes and macrophages through the colony-stimulating factor-1 receptor (CSF1R; MIM 164770) (Lin et al., 2008 [PubMed 18467591]). |
| Source : | CHO |
| Species : | Human |
| Tag : | Fc |
| Form : | Lyophilized from 0.2μm-filtered solution in PBS. |
| Molecular Mass : | 51 KDa |
| Protein length : | Asn21-Pro242 |
| Endotoxin : | <0.06 EU/μg as determined by LAL test. |
| Purity : | >98%,by SDS-PAGE under reducing conditions. |
| Storage : | Stable for at least 1 year after receipt when stored at -20 centigrade. Working aliquots are stable for up to 3 months. when stored at -20 centigrade. |
| Reconstitution : | Reconstitute at 100μg/ml in sterile PBS. |
| Gene Name : | IL34 interleukin 34 [ Homo sapiens ] |
| Official Symbol : | IL34 |
| Synonyms : | IL34; interleukin 34; C16orf77, chromosome 16 open reading frame 77; interleukin-34; IL 34; MGC34647; IL-34; C16orf77; |
| Gene ID : | 146433 |
| mRNA Refseq : | NM_001172771 |
| Protein Refseq : | NP_001166242 |
| MIM : | 612081 |
| UniProt ID : | Q6ZMJ4 |
| Chromosome Location : | 16q22.1 |
| Function : | cytokine activity; growth factor activity; macrophage colony-stimulating factor receptor binding; |
Products Types
| ◆ Lysates | ||
| IL34-2783MCL | Recombinant Mouse IL34 cell lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (6)
Ask a questionThere are no clear studies showing the effect of IL34 on tumor prognosis.
Can fight disease by modulating the immune system and may have better efficacy and fewer side effects than other treatments.
May inhibit tumor growth and metastasis by enhancing immune cells' ability to attack tumor cells.
No large-scale clinical trials have been reported, but some early studies have shown a potential therapeutic effect.
Regulate the function of macrophages and dendritic cells and affect the immune response of the immune system.
The evaluation of the efficacy of IL34 usually requires a comprehensive evaluation of clinical symptoms, biochemical indicators, imaging and other indicators.
Customer Reviews (3)
Write a reviewIL34 has shown good biocompatibility and safety in related experiments. -
When using IL34 for experiments, the experimental conditions and results are highly repeatable. -
Quality is stable and reliable, with no significant differences between batches. -
Ask a Question for All IL34 Products
Required fields are marked with *
My Review for All IL34 Products
Required fields are marked with *
Inquiry Basket
